Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
30,284,111
-
Total 13F shares
-
12,875,335
-
Share change
-
-309,091
-
Total reported value
-
$546,804,079
-
Price per share
-
$42.47
-
Number of holders
-
77
-
Value change
-
-$44,327,639
-
Number of buys
-
49
-
Number of sells
-
33
Institutional Holders of Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS) as of Q2 2021
As of 30 Jun 2021 Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS) had 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 12,875,335 shares of stock of the company.
Largest 10 holders included FMR LLC, ORBIMED ADVISORS LLC, Consonance Capital Management LP, ALKEON CAPITAL MANAGEMENT LLC, STATE STREET CORP, VANGUARD GROUP INC, Nantahala Capital Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, Point72 Asset Management, L.P., and FRANKLIN RESOURCES INC.
This table shows 78 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.